Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine Long-term Extension in MDD
NCT01323478Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Apr 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), sponsored by Lundbeck. Started Apr 2011; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01323478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323478.